Skip to main content

Table 2 Performance of seven algorithms under the 100 trials of 50% HOCV

From: A high performance profile-biomarker diagnosis for mass spectral profiles

Dataset Ave. classification rate ± std (%) Ave. sensitivity ± std (%) Ave. specificity ± std (%)
Colorectal    
mica-svm 99.05±01.82 98.84±03.41 99.28±01.82
svm 95.71±02.01 95.28±03.67 96.19±02.88
pca-svm 95.37±01.98 93.60±04.18 96.83±02.93
ica-svm 95.57±02.02 93.69±04.11 97.11±02.81
nmf-svm 92.46±02.97 89.91±06.92 94.65±04.04
lda 87.39±04.60 84.97±07.56 89.36±06.11
pca-lda 94.21±02.75 93.87±03.64 94.51±04.03
HCC    
mica-svm 99.07±01.03 98.82±01.73 99.31±01.62
svm 93.08±02.33 93.42±03.55 92.95±04.12
pca-svm 89.65±02.86 89.09±04.46 90.33±04.59
ica-svm 90.15±02.63 89.76±04.27 90.70±04.35
nmf-svm 89.81±03.17 87.68±07.28 92.22±05.14
lda 89.48±03.67 91.55±04.42 87.75±06.88
pca-lda 91.20±02.81 90.08±05.18 92.38±03.62
Ovarian-qaqc    
mica-svm 99.09±01.09 98.94±02.15 99.25±01.11
svm 97.64±01.36 97.42±02.04 97.86±02.18
pca-svm 98.63±00.88 99.28±01.20 98.12±01.58
ica-svm 98.52±00.83 99.06±01.30 98.10±01.50
nmf-svm 92.47±03.23 94.23±03.72 91.15±04.89
lda 81.42±04.48 87.86±05.17 76.26±06.91
pca-lda 98.42±01.04 99.30±01.13 97.73±01.94
Prostate    
mica-svm 99.36±00.99 99.09±01.43 99.64±01.66
svm 95.91±02.09 95.75±03.05 96.18±03.99
pca-svm 97.94±01.65 98.48±01.70 97.43±03.24
ica-svm 98.23±01.61 98.36±01.84 98.14±02.84
nmf-svm 91.21±04.67 94.44±04.70 87.46±06.69
lda 89.92±04.77 94.43±04.65 85.02±10.46
pca-lda 97.50±02.20 97.90±02.50 97.10±03.25
Cirrhotic    
mica-svm 99.52±00.85 99.44±01.65 99.62±00.95
svm 95.10± 03.17 92.97± 05.91 96.71± 03.10
pca-svm 91.52± 03.76 88.00± 08.39 94.15± 03.86
ica-svm 92.07± 03.41 88.47± 07.92 94.72± 03.48
nmf-svm 88.03±03.10 80.43±07.84 93.42±03.62
lda 86.66±06.11 86.57±10.30 86.93±08.19
pca-lda 92.39±03.62 89.04±07.45 94.83±03.48